Concepedia

Publication | Open Access

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2

DOIFull Paper Access

941

Citations

18

References

2019

Year

George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman,
JAMA Oncology

Abstract

ClinicalTrials.gov identifier: NCT02107703.

References

YearCitations

Page 1